Penserra Capital Management LLC increased its holdings in shares of BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report) by 11.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,303,212 shares of the company’s stock after purchasing an additional 132,104 shares during the period. Penserra Capital Management LLC owned 1.21% of BlackRock Capital Allocation Term Trust worth $19,274,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently added to or reduced their stakes in the stock. Geneos Wealth Management Inc. boosted its position in shares of BlackRock Capital Allocation Term Trust by 341.7% in the second quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company’s stock worth $31,000 after buying an additional 1,582 shares during the period. AdvisorNet Financial Inc lifted its position in BlackRock Capital Allocation Term Trust by 53.8% during the 3rd quarter. AdvisorNet Financial Inc now owns 2,995 shares of the company’s stock worth $44,000 after acquiring an additional 1,048 shares in the last quarter. McIlrath & Eck LLC boosted its holdings in BlackRock Capital Allocation Term Trust by 971.1% in the 3rd quarter. McIlrath & Eck LLC now owns 2,999 shares of the company’s stock worth $44,000 after acquiring an additional 2,719 shares during the period. B. Riley Wealth Advisors Inc. purchased a new position in BlackRock Capital Allocation Term Trust in the 3rd quarter worth approximately $151,000. Finally, NewEdge Advisors LLC acquired a new stake in BlackRock Capital Allocation Term Trust in the second quarter valued at approximately $233,000. 36.12% of the stock is owned by hedge funds and other institutional investors.
BlackRock Capital Allocation Term Trust Price Performance
NYSE BCAT opened at $14.72 on Thursday. The company’s fifty day simple moving average is $14.46 and its 200-day simple moving average is $14.65. BlackRock Capital Allocation Term Trust has a 52 week low of $12.91 and a 52 week high of $15.91.
BlackRock Capital Allocation Term Trust Announces Dividend
BlackRock Capital Allocation Term Trust Profile
BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.
BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.
Read More
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- The day the gold market broke
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Trump Planning to Use Public Law 63-43: Prepare Now
- Forget AI, This Will Be the Next Big Tech Breakthrough
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
